Artificial Intelligence has Similar Performance to Subjective Assessment of Emphysema Severity on Chest CT.


Journal

Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159

Informations de publication

Date de publication:
08 2022
Historique:
received: 21 07 2021
revised: 03 09 2021
accepted: 06 09 2021
pubmed: 19 10 2021
medline: 19 7 2022
entrez: 18 10 2021
Statut: ppublish

Résumé

To compare an artificial intelligence (AI)-based prototype and subjective grading for predicting disease severity in patients with emphysema. Our IRB approved HIPAA-compliant study included 113 adults (71±8 years; 47 females, 66 males) who had both non-contrast chest CT and pulmonary function tests performed within a span of 2 months. The disease severity was classified based on the forced expiratory volume in 1 second (FEV1 as % of predicted) into mild, moderate, and severe. 2 thoracic radiologists (RA), blinded to the clinical and AI results, graded severity of emphysema on a 5-point scale suggested by the Fleischner Society for each lobe. The whole lung scores were derived from the summation of lobar scores. Thin-section CT images were processed with the AI-Rad Companion Chest prototype (Siemens Healthineers) to quantify low attenuation areas (LAA < - 950 HU) in whole lung and each lobe separately. Bronchial abnormality was assessed by both radiologists and a fully automated software (Philips Healthcare). Both AI (AUC of 0.77; 95% CI: 0.68 - 0.85) and RA (AUC: 0.76, 95% CI: 0.65 - 0.84) emphysema quantification could differentiate mild, moderate, and severe disease based on FEV1. There was a strong positive correlation between AI and RA (r = 0.72 - 0.80; p <0.001). The combination of emphysema and bronchial abnormality quantification from radiologists' and AI assessment could differentiate between different severities with AUC of 0.80 - 0.82 and 0.87, respectively. The assessed AI-prototypes can predict the disease severity in patients with emphysema with the same predictive value as the radiologists.

Identifiants

pubmed: 34657812
pii: S1076-6332(21)00421-9
doi: 10.1016/j.acra.2021.09.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1195

Informations de copyright

Copyright © 2021 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Auteurs

Shadi Ebrahimian (S)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Subba R Digumarthy (SR)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Bernardo Bizzo (B)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; MGH and BWH Center for Clinical Data Science, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, Massachusetts.

Andrew Primak (A)

Siemens Medical Solutions USA Inc., Malvern, Pennsylvania.

Mathis Zimmermann (M)

Siemens Healthcare GmbH, Diagnostic Imaging, Erlangen, Germany.

Mohammad Mahmoud Tarbiah (MM)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Medical student, University of Jordan, Amman, Jordan.

Mannudeep K Kalra (MK)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: MKALRA@mgh.harvard.edu.

Keith J Dreyer (KJ)

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; MGH and BWH Center for Clinical Data Science, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH